8-K
Current Report
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001193125-13-304964
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading d573698d8k.htm…